Literature DB >> 30900950

Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma.

Qiuli Li1,2,3, Weichao Chen1,2,3, Ming Song1,2,3, Wenkuan Chen1,2,3, Zhongyuan Yang1,2,3, Ankui Yang1,2,3.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a lethal disease with suboptimal survival outcomes. In this study, we aimed to find an independent prognostic factor of head and neck squamous cell carcinoma and investigate its effect on tumor cell proliferation, apoptosis, migration progress and cell cycle phase. Weighted gene co-expression network analysis (WGCNA) is an analysis method for mining module information in chip data through soft threshold. In this article, it was used to divide differential genes into different modules and determined the ten hub genes. Overall survival (OS) and disease-free survival (DFS) analyses as well as univariate and multivariate regression analyses were used to figure out HMGA2 as the independent prognostic factor. RT-qPCR and western blot results revealed the HMGA2 expression levels. Via colony formation, flow cytometry and wound healing assays, we tested the involvement of HMGA2 knockdown in corresponding cancer cell biological behaviors. HMGA2 level was up-regulated in HNSCC tissues and cell lines (SCC-25 and FaDu) in comparison with their normal counterparts. HMGA2 knockdown decreased cancer cell proliferation, promoted cell apoptosis, blocked cell cycle at G0/G1 phase, and inhibited cell migration. We regarded HMGA2 as a potential diagnostic and therapeutic target of HNSCC.

Entities:  

Keywords:  HMGA2; HNSCC; WGCNA; hub gene; prognostic analysis

Year:  2019        PMID: 30900950      PMCID: PMC6605996          DOI: 10.1080/15384047.2018.1564560

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

1.  Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer.

Authors:  G L Yang; L H Zhang; J J Bo; K L Hou; X Cai; Y Y Chen; H Li; D M Liu; Y R Huang
Journal:  Eur J Surg Oncol       Date:  2011-01-26       Impact factor: 4.424

2.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

3.  MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2.

Authors:  Huading Zhou; Weijie Guo; Yingjun Zhao; Yifei Wang; Ruopeng Zha; Jie Ding; Linhui Liang; Jun Hu; Hao Shen; Zongyou Chen; Baobing Yin; Baojin Ma
Journal:  Int J Oncol       Date:  2014-03-27       Impact factor: 5.650

4.  Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.

Authors:  Takashi Kinoshita; Nijiro Nohata; Miki Fuse; Toyoyuki Hanazawa; Naoko Kikkawa; Lisa Fujimura; Haruko Watanabe-Takano; Yasutoshi Yamada; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  Biochem Biophys Res Commun       Date:  2012-01-12       Impact factor: 3.575

5.  Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

Authors:  Xiaochen Wang; Xiyong Liu; Angela Ying-Jian Li; Lirong Chen; Lily Lai; Her Helen Lin; Shuya Hu; Lifang Yao; Jiaping Peng; Sofia Loera; Lijun Xue; Bingsen Zhou; Lun Zhou; Shu Zheng; Peiguo Chu; Suzhan Zhang; David Kong Ann; Yun Yen
Journal:  Clin Cancer Res       Date:  2011-01-20       Impact factor: 12.531

6.  High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.

Authors:  Chung-Ta Lee; Tsung-Teh Wu; Christine M Lohse; Lizhi Zhang
Journal:  Hum Pathol       Date:  2014-08-23       Impact factor: 3.466

7.  Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.

Authors:  Hiroshi Yamazaki; Taisuke Mori; Masaki Yazawa; Akiko M Maeshima; Fumihiko Matsumoto; Seiichi Yoshimoto; Yoshihide Ota; Akihiro Kaneko; Hitoshi Tsuda; Yae Kanai
Journal:  Lab Invest       Date:  2013-10-21       Impact factor: 5.662

8.  Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.

Authors:  Qiong Zou; Li Xiong; Zhulin Yang; Fang Lv; Leping Yang; Xiongying Miao
Journal:  World J Surg Oncol       Date:  2012-05-21       Impact factor: 2.754

9.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.

Authors:  Carla Hebert; Kathleen Norris; Mark A Scheper; Nikolaos Nikitakis; John J Sauk
Journal:  Mol Cancer       Date:  2007-01-14       Impact factor: 27.401

10.  WGCNA: an R package for weighted correlation network analysis.

Authors:  Peter Langfelder; Steve Horvath
Journal:  BMC Bioinformatics       Date:  2008-12-29       Impact factor: 3.169

View more
  3 in total

1.  SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53.

Authors:  Fengjuan Chen; Ka Zhang; Yilin Huang; Fang Luo; Kunpeng Hu; Qingxian Cai
Journal:  FEBS Open Bio       Date:  2020-06-07       Impact factor: 2.693

2.  Construction and validation of an eight-gene signature with great prognostic value in bladder cancer.

Authors:  Xin Yan; Xun Fu; Zi-Xin Guo; Xiao-Ping Liu; Tong-Zu Liu; Sheng Li
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

3.  Expression of 5-methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence.

Authors:  Lin Wang; Guoping Ren; Biaoyang Lin
Journal:  Cancer Med       Date:  2021-07-05       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.